Bonne Sante Group
Doral, US · Founded 2017 · Delaware corporation
Founders & leadership
AC
Alfonso CervantesNamed on SEC filing
DM
Darren MintonNamed on SEC filing
AB
Alan BergmanNamed on SEC filing
RZ
Ryan ZackonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$11.6M disclosed across 4 rounds · 2017–2022
▶$1MraisedDec 2022 · 5 investors · Other Health CareRule 506(b)
▶$1MraisedDec 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert ReinDirector
- Darren MintonExecutive Officer, Director
- Arthur ReynoldsDirector
- Alfonso J. Cervantes, Jr.Executive Officer, Director
- Ronald S. AltbachDirector
- Alan B. BergmanExecutive Officer
- Roger Conley WoodDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Sales commissions
- $90K
- Placement agents
- DAWSON JAMES SECURITIES, INC.
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$250KraisedJan 2022 · 3 investors · Other Health CareRule 506(b)
▶$250KraisedJan 2022 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Darren MintonExecutive Officer, Director
- Ryan ZackonExecutive Officer, Director
- Alan BergmanExecutive Officer
- Alfonso CervantesExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $250K
- Minimum investment
- $50K
- Placement agents
- DAWSON JAMES SECURITIES, INC.
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$6MraisedJul 2021 · 5 investors · Other Health CareRule 506(b)
▶$6MraisedJul 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alfonso CervantesExecutive Officer, Director
- Darren MintonExecutive Officer, Director
- Alan BergmanExecutive Officer
- Ryan ZackonExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $6M
- Sales commissions
- $540K
- Placement agents
- DAWSON JAMES SECURITIES, INC.
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$4.3MraisedMar 2021 · 66 investors · Other Health CareRule 506(b)
▶$4.3MraisedMar 2021 · 66 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan ZackonExecutive Officer, Director
- Darren MintonExecutive Officer, Director
- Alan BergmanExecutive Officer
- Alfonso CervantesExecutive Officer, Director
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- Minimum investment
- $10K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Bonne Sante Group raised?
- Bonne Sante Group has disclosed $11.6M raised across 4 rounds.
- Where is Bonne Sante Group headquartered?
- Bonne Sante Group is headquartered in Doral, US.